In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
201 News Items found
Colorectal Surgeon Dr. Julio Garcia-Aguilar seen smiling in office.
New Colorectal Cancer Treatments at MSK Aim To Reduce Deaths in 2026 and Beyond

Learn about the latest treatments for colon and rectal (colorectal) cancer at Memorial Sloan Kettering Cancer Center.
Photo of Chadwick Boseman
Black Men and Women Are at Higher Risk of Colorectal Cancer: What You Should Know

Black adults are more likely to get colorectal cancer and die from it than any other group. Learn how Black men and women can protect themselves and why screening for colorectal cancer beginning at age 45 is so important.
Dr. Robin Mendelsohn
Is Shield a Good Colorectal Cancer Screening Blood Test? Hear From an MSK Expert 

MSK experts say the Shield blood test is not the best way to detect colorectal cancer and instead recommend colonoscopy or a stool test for those who can’t have a colonoscopy.
Rosario Costas-Muñiz is a psycho-oncologist focused on the needs of the Latino community.
Helping Latinos Prevent Colon Cancer: Good News about Screening

Learn from an MSK specialist in cancer care for the Latino community about screening for colorectal cancer, to help prevent the disease.
MSK gastroenterologist Robin Mendelsohn seen smiling at desk.
How Does an At-Home Colorectal Cancer Screening Test Compare to a Colonoscopy? Answers From an Expert at Memorial Sloan Kettering Cancer Center

Learn about the difference methods of colorectal cancer screening, including the at-home Cologuard test, from an expert at Memorial Sloan Kettering Cancer Center.
MSK computational biologist Henry Walch
Why Is Colorectal Cancer in African Americans Hard To Treat? One Reason Is Genetics

African American patients with colorectal cancer are less likely to have tumors that respond well to newer treatments such as targeted therapy and immunotherapy.
MSK medical oncologist Michael Foote, MD, is seen smiling in a hallway.
Just Diagnosed With Colorectal Cancer? What You Should Do Next

Learn what to do right after you've been diagnosed with colorectal cancer, from an MSK expert who specializes in treating this kind of cancer.
Dr. Rona Yaeger
FDA Approves First Colorectal Cancer Treatment that Targets G12C KRAS Gene

The targeted therapy adagrasib received accelerated approved for colorectal cancer caused by a mutation called KRAS-G12C, when used in combination with the drug cetuximab. MSK investigators have led much of the research that resulted in this combined drug approval.
Colorectal Tumors in Young vs. Older Adults Are Biologically Similar, Says MSK Study

The largest, most comprehensive study of its kind from Memorial Sloan Kettering Cancer Center finds that the biology of colorectal cancer in people under 50 is very similar to the disease in older people and more aggressive treatment of younger patients may not be warranted.
Studies have suggested that aspirin can reduce the risk of cancer, but there can be serious side effects from taking it every day.
In the Clinic
Does an Aspirin a Day Reduce the Risk of Colorectal Cancer?

MSK gastroenterologist Robin Mendelsohn weighs in on the possible benefits and drawbacks of using aspirin to reduce the risk of colon and rectal cancer.